z-logo
open-access-imgOpen Access
The effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in differentiated thyroid carcinoma
Author(s) -
Nazlı Gülsoy Kirnap,
Özlem Turhan İyidir,
Yusuf Bozkuş,
Şerife Mehlika Işildak,
Cüneyd Anıl,
Sevde Nur Fırat,
Canan Demir,
Aslı Nar,
Neslihan Başçıl Tütüncü
Publication year - 2020
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-1902-176
Subject(s) - euthyroid , medicine , subclinical infection , anxiety , depression (economics) , thyroid , quality of life (healthcare) , thyroid carcinoma , beck anxiety inventory , endocrinology , gastroenterology , beck depression inventory , psychiatry , nursing , economics , macroeconomics
Overt thyroidism is known to cause neuropsychiatric disorders but studies on subclinical hyperthyroidism (SCH) are limited. Subclinical hyperthyroidism induction by administering L-Thyroxine (LT4) is the standard treatment method in differentiated thyroid carcinoma (DTC) follow-up. Our aim was to investigate whether anxiety, depression and quality of life are affected in DTC patients followed-up with exogenous SCH.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom